Skip to content
10-Q

Quarterly Report

BICYCLE THERAPEUTICS PLC BCYC

0001104659-25-104010

← back to feed
Filed
Oct 30, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted Q3 2025 · Sep 30, 2025 69.3M sh
Shares Diluted Q3 2025 · Sep 30, 2025 69.25M sh
Shares Diluted Q3 2025 · Sep 30, 2024 68.99M sh
Shares Diluted Q3 2025 · Sep 30, 2024 54.57M sh
Capex Q3 2025 · Sep 30, 2025 $1.78M
Capex Q3 2025 · Sep 30, 2024 $867K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$230.33M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$155.33M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $648.33M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $879.52M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $890.86M
Stockholders Equity Q3 2025 · Sep 30, 2025 $618.48M
Stockholders Equity Q3 2025 · Jun 30, 2025 $668.92M
Stockholders Equity Q3 2025 · Mar 31, 2025 $740.33M
Stockholders Equity Q3 2025 · Dec 31, 2024 $793.06M
Stockholders Equity Q3 2025 · Sep 30, 2024 $831.03M
Stockholders Equity Q3 2025 · Jun 30, 2024 $873.81M
Stockholders Equity Q3 2025 · Mar 31, 2024 $356.05M
Stockholders Equity Q3 2025 · Dec 31, 2023 $370.93M
Current Liabilities Q3 2025 · Sep 30, 2025 $69.28M
Current Liabilities Q3 2025 · Dec 31, 2024 $67.23M
Total Liabilities Q3 2025 · Sep 30, 2025 $145.48M
Total Liabilities Q3 2025 · Dec 31, 2024 $163.81M
Current Assets Q3 2025 · Sep 30, 2025 $738.82M
Current Assets Q3 2025 · Dec 31, 2024 $928.61M
Total Assets Q3 2025 · Sep 30, 2025 $763.95M
Total Assets Q3 2025 · Dec 31, 2024 $956.87M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.85
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.87
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.74
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.15
Eps Basic Q3 2025 · Sep 30, 2025 −$0.85
Eps Basic Q3 2025 · Sep 30, 2025 −$2.87
Eps Basic Q3 2025 · Sep 30, 2024 −$0.74
Eps Basic Q3 2025 · Sep 30, 2024 −$2.15
Sga Expense Q3 2025 · Sep 30, 2025 $18.86M
Sga Expense Q3 2025 · Sep 30, 2025 $58.48M
Sga Expense Q3 2025 · Sep 30, 2024 $18.26M
Sga Expense Q3 2025 · Sep 30, 2024 $50.59M
Rd Expense Q3 2025 · Sep 30, 2025 $58.43M
Rd Expense Q3 2025 · Sep 30, 2025 $188.51M
Rd Expense Q3 2025 · Sep 30, 2024 $48.27M
Rd Expense Q3 2025 · Sep 30, 2024 $123.19M
Net Income Q3 2025 · Sep 30, 2025 −$59.1M
Net Income Q3 2025 · Sep 30, 2025 −$198.81M
Net Income Q3 2025 · Jun 30, 2025 −$78.95M
Net Income Q3 2025 · Mar 31, 2025 −$60.75M
Net Income Q3 2025 · Sep 30, 2024 −$50.8M
Net Income Q3 2025 · Sep 30, 2024 −$117.18M
Net Income Q3 2025 · Jun 30, 2024 −$39.81M
Net Income Q3 2025 · Mar 31, 2024 −$26.56M
Operating Income Q3 2025 · Sep 30, 2025 −$65.55M
Operating Income Q3 2025 · Sep 30, 2025 −$222.36M
Operating Income Q3 2025 · Sep 30, 2024 −$63.85M
Operating Income Q3 2025 · Sep 30, 2024 −$142.21M
Revenue Q3 2025 · Sep 30, 2025 $11.73M
Revenue Q3 2025 · Sep 30, 2025 $24.63M
Revenue Q3 2025 · Sep 30, 2024 $2.68M
Revenue Q3 2025 · Sep 30, 2024 $31.57M